|
|
|||||||||
Basic Science Investigations |
Division of Nuclear Medicine, Department of Radiology, Johns Hopkins Medical Institutions, Baltimore, Maryland
Physiologic 18F-FDG uptake in areas of supraclavicular fat in humans ("USA-Fat") has recently been recognized as 18F-FDG uptake in apparent brown adipose tissue (BAT) using fused PET/CT technology. In this study, we evaluated 18F-FDG uptake in BAT of rats to determine whether pharmacologic or physiologic interventions affect the uptake, knowing that BAT has a high density of adrenergic innervation. Methods: Seven- to 8-wk-old female Lewis rats receiving intravenous 18F-FDG injections were examined under various conditions to evaluate 18F-FDG biodistribution into interscapular BAT and major organs. In series 1, rats were given ketamine-based anesthesia or were exposed to cold (4°C for 4 h) to determine whether these interventions increased 18F-FDG uptake in BAT. In series 2, anesthetized rats (ketamine-based anesthesia) were given propranolol, reserpine, or diazepam intraperitoneally before 18F-FDG injection to determine whether the drug reduced 18F-FDG uptake in BAT. The control and treated groups in series 2 were also evaluated with 18F-FDG PET/CT imaging. Results: In series 1, anesthesia or exposure to cold increased 18F-FDG uptake in BAT to levels 14-fold and 4.9-fold, respectively, greater than the control nonstimulated values. BAT uptake was high, comparable to that in the brain. In series 2, 18F-FDG uptake in BAT was significantly decreased to less than 30% of the control level after propranolol or reserpine (P < 0.05). Diazepam did not significantly decrease 18F-FDG uptake in BAT. 18F-FDG PET/CT findings reflected these biodistribution data: The control and diazepam groups exhibited intense 18F-FDG uptake in BAT, whereas the propranolol and reserpine groups showed only faint to mild 18F-FDG uptake in BAT. Among several organs whose 18F-FDG uptake was affected after predosing drugs, the heart exhibited considerable decreases in tracer uptake with propranolol or reserpine. Conclusion: This rodent study demonstrated that BAT can exhibit high 18F-FDG uptake under stimulated conditions including exposure to cold and that propranolol or reserpine treatment can remarkably reduce the high 18F-FDG uptake in BAT. The effect of these drugs on 18F-FDG uptake in human BAT, as well as on tracer accumulation in other organs, should carefully be evaluated clinically to minimize the USA-Fat artifact.
Key Words: brown fat 18F-FDG rat PET/CT
Related articles in JNM:
This article has been cited by other articles:
![]() |
T. S. Aukema, W. V. Vogel, C. A. Hoefnagel, and R. A. Valdes Olmos Prevention of Brown Adipose Tissue Activation in 18F-FDG PET/CT of Breast Cancer Patients Receiving Neoadjuvant Systemic Therapy J. Nucl. Med. Technol., March 1, 2010; 38(1): 24 - 27. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baba, H. A. Jacene, J. M. Engles, H. Honda, and R. L. Wahl CT Hounsfield Units of Brown Adipose Tissue Increase with Activation: Preclinical and Clinical Studies J. Nucl. Med., February 1, 2010; 51(2): 246 - 250. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sanchez-Alavez, I. V. Tabarean, O. Osborn, K. Mitsukawa, J. Schaefer, J. Dubins, K. H. Holmberg, I. Klein, J. Klaus, L. F. Gomez, et al. Insulin Causes Hyperthermia by Direct Inhibition of Warm-Sensitive Neurons Diabetes, January 1, 2010; 59(1): 43 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
A AGRAWAL, N NAIR, and N S BAGHEL A novel approach for reduction of brown fat uptake on FDG PET Br. J. Radiol., August 1, 2009; 82(980): 626 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman, A. B. Goldfine, F. C. Kuo, E. L. Palmer, Y.-H. Tseng, A. Doria, et al. Identification and Importance of Brown Adipose Tissue in Adult Humans N. Engl. J. Med., April 9, 2009; 360(15): 1509 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. S. Celi Brown Adipose Tissue -- When It Pays to Be Inefficient N. Engl. J. Med., April 9, 2009; 360(15): 1553 - 1556. [Full Text] [PDF] |
||||
![]() |
P. Seale, S. Kajimura, and B. M. Spiegelman Transcriptional control of brown adipocyte development and physiological function--of mice and men Genes & Dev., April 1, 2009; 23(7): 788 - 797. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Williams and G. M. Kolodny Method for Decreasing Uptake of 18F-FDG by Hypermetabolic Brown Adipose Tissue on PET Am. J. Roentgenol., May 1, 2008; 190(5): 1406 - 1409. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baba, J. M. Engles, D. L. Huso, T. Ishimori, and R. L. Wahl Comparison of Uptake of Multiple Clinical Radiotracers into Brown Adipose Tissue Under Cold-Stimulated and Nonstimulated Conditions J. Nucl. Med., October 1, 2007; 48(10): 1715 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nedergaard, T. Bengtsson, and B. Cannon Unexpected evidence for active brown adipose tissue in adult humans Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E444 - E452. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hadi, C. C. Chen, M. Whatley, K. Pacak, and J. A. Carrasquillo Brown Fat Imaging with 18F-6-Fluorodopamine PET/CT, 18F-FDG PET/CT, and 123I-MIBG SPECT: A Study of Patients Being Evaluated for Pheochromocytoma J. Nucl. Med., July 1, 2007; 48(7): 1077 - 1083. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Baba, M. Tatsumi, T. Ishimori, D. L. Lilien, J. M. Engles, and R. L. Wahl Effect of Nicotine and Ephedrine on the Accumulation of 18F-FDG in Brown Adipose Tissue J. Nucl. Med., June 1, 2007; 48(6): 981 - 986. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. EVANS, T. A. TULLOSS, and N. HALL 18FDG Uptake in Brown Fat: Potential for False Positives Radiol. Technol., May 1, 2007; 78(5): 361 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Fueger, J. Czernin, I. Hildebrandt, C. Tran, B. S. Halpern, D. Stout, M. E. Phelps, and W. A. Weber Impact of Animal Handling on the Results of 18F-FDG PET Studies in Mice J. Nucl. Med., June 1, 2006; 47(6): 999 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Weber Brown Adipose Tissue and Nuclear Medicine Imaging J. Nucl. Med., July 1, 2004; 45(7): 1101 - 1103. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | RSS | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |